6F/7F MynxGrip Vascular Closure Device; Product Model MX6721, Product Usage: The 6F/7F MynxGrip Vascular Closure Device is indicated for use to seal femoral arterial and femoral venous access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 6F or 7F procedural sheath. The 6F/7F MynxGrip Vascular Closure Device is designed to achieve femoral artery and femoral vein hemostasis via delivery of an extravascular, water-soluble synthetic sealant using a balloon catheter in conjunction with a standard procedural sheath. The sealant is comprised of a polyethylene glycol (PEG) material which expands upon contact with subcutaneous fluids to seal the arteriotomy or venotomy. The sealant is resorbed by the body within 30-days.
Published August 10, 2016 · Recall initiated: July 13, 2016
Summary
FDA records medical device Class II recall Z-2329-2016, published August 10, 2016 and initiated July 13, 2016. Recalling firm: AccessClosure, Inc., A Cardinal Health Company; Status: Terminated; Reported quantity: 55 units; Lot: Lot No: F1609702, Expiry 4/20/2018; Lot No. F1534302, Expiry 12/31/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AccessClosure, Inc., A Cardinal Health Company
- Distributor
- US in the states of CA, and MS.
- Lot
- Lot No: F1609702, Expiry 4/20/2018; Lot No. F1534302, Expiry 12/31/2016
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAThe PAXWIRE Occlusion Balloon System consists of an occlusion catheter, inflation handle and syringes. It isNovember 2, 2016
- FDARePlant® Angled Abutment Part Number 6050-52-60August 10, 2016
- FDAZimmer® Air Dermatome II Width Plate, 2 inch. Part # 885120200. Width plate is packaged inside of aAugust 10, 2016
- FDAS7 MACH FrameLink. The software application is sent in CD format with an IFU, wrapped in plastic with a labelAugust 10, 2016
- FDA91496 Ultraview SL Command Module, Options A, B, C, and I. Option A: ECG/Respiration, SpO2, Temperature x2 &August 10, 2016
- FDAAU680 Chemistry Analyzers, Reference No. B04779 The AU series are automated, clinical chemistry analyzers thatAugust 10, 2016
Questions about this recall
Was 6F/7F MynxGrip Vascular Closure Device; Product Model MX6721, Product Usage: The 6F/7F MynxGrip Vascular Closure Device is indicated for use to seal femoral arterial and femoral venous access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 6F or 7F procedural sheath. The 6F/7F MynxGrip Vascular Closure Device is designed to achieve femoral artery and femoral vein hemostasis via delivery of an extravascular, water-soluble synthetic sealant using a balloon catheter in conjunction with a standard procedural sheath. The sealant is comprised of a polyethylene glycol (PEG) material which expands upon contact with subcutaneous fluids to seal the arteriotomy or venotomy. The sealant is resorbed by the body within 30-days. recalled?
Yes. FDA published recall Z-2329-2016 on August 10, 2016. Reported hazard: A total of 70 6F/7F Mynx Grip devices were shipped from a distributor using improper transport/packaging configurations.
What should I do if I have this product?
Voluntary: Firm initiated · Letter